ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ARS PHARMACEUTICALS, INC.

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY)
Listen to this Section


$8.49
+0.4690 ( +5.85% ) 2.0M

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Market Data


Open $8.49
Previous Close $8.02
Volume 2.0M
Market Cap $1.05B
Day Range $7.82 - $8.96
52 Week Range $6.66 - $18.90
Shares Outstanding 99.30M
Change % +5.85%
Net Change ▲ 0.4690
Insider Ownership -0.24%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2022
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -1,273,987.00

Date Type Amount Purchased Purchaser
2024-03-27 Buy 437600.00 RA CAPITAL MANAGEMENT, L.P.
2024-03-26 Sale -1017.00 Lowenthal Richard E
2024-03-26 Sale -1017.00 Tanimoto Sarina
2024-03-21 Sale -976.00 Lowenthal Richard E
2024-03-21 Sale -976.00 Tanimoto Sarina
2024-03-15 Sale -1500.00 Tanimoto Sarina
2024-03-15 Sale -1500.00 Lowenthal Richard E
2024-03-01 Sale -800.00 Tanimoto Sarina
2024-03-01 Sale -800.00 Lowenthal Richard E
2024-02-28 Sale -100.00 Tanimoto Sarina

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 83 Nov 10, 2025
8-k 8K-related 33 Nov 10, 2025
8-k 8K-related 13 Sep 29, 2025
8-k 8K-related 12 Aug 28, 2025
4 Insider transactions 1 Aug 22, 2025
4 Insider transactions 1 Aug 22, 2025
4 Insider transactions 1 Aug 21, 2025
10-q Quarterly Reports 81 Aug 13, 2025
8-k 8K-related 32 Aug 13, 2025
4 Insider transactions 1 Jul 03, 2025

Latest News